These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 15634269)
1. Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. Bank I; Libourel EJ; Middeldorp S; Hamulyák K; van Pampus EC; Koopman MM; Prins MH; van der Meer J; Büller HR J Thromb Haemost; 2005 Jan; 3(1):79-84. PubMed ID: 15634269 [TBL] [Abstract][Full Text] [Related]
2. Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study. Bank I; van de Poel MH; Coppens M; Hamulyák K; Prins MH; van der Meer J; Veeger NJ; Büller HR; Middeldorp S Thromb Haemost; 2007 Nov; 98(5):1040-4. PubMed ID: 18000609 [TBL] [Abstract][Full Text] [Related]
3. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Bank I; Libourel EJ; Middeldorp S; Van Pampus EC; Koopman MM; Hamulyák K; Prins MH; Van Der Meer J; Büller HR Arch Intern Med; 2004 Sep; 164(17):1932-7. PubMed ID: 15451770 [TBL] [Abstract][Full Text] [Related]
4. Familial clustering of high factor VIII levels in patients with venous thromboembolism. Schambeck CM; Hinney K; Haubitz I; Mansouri Taleghani B; Wahler D; Keller F Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):289-92. PubMed ID: 11156867 [TBL] [Abstract][Full Text] [Related]
5. High plasma levels of factor VIII and risk of recurrence of venous thromboembolism. Cristina L; Benilde C; Michela C; Mirella F; Giuliana G; Gualtiero P Br J Haematol; 2004 Feb; 124(4):504-10. PubMed ID: 14984502 [TBL] [Abstract][Full Text] [Related]
6. Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis. Hoppener MR; Kraaijenhagen RA; Hutten BA; Büller HR; Peters RJ; Levi M J Thromb Haemost; 2004 Aug; 2(8):1316-20. PubMed ID: 15304037 [TBL] [Abstract][Full Text] [Related]
7. Elevated plasma factor VIII levels--a novel risk factor for venous thromboembolism. O'Donnell J; Laffan M Clin Lab; 2001; 47(1-2):1-6. PubMed ID: 11214218 [TBL] [Abstract][Full Text] [Related]
8. Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study. Libourel EJ; Bank I; Veeger NJ; Hamulyàk K; Middeldorp S; Prins MH; Büller HR; van der Meer J Blood Coagul Fibrinolysis; 2005 Mar; 16(2):135-40. PubMed ID: 15741801 [TBL] [Abstract][Full Text] [Related]
9. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor. Rietveld IM; Lijfering WM; le Cessie S; Bos MHA; Rosendaal FR; Reitsma PH; Cannegieter SC J Thromb Haemost; 2019 Jan; 17(1):99-109. PubMed ID: 30471183 [TBL] [Abstract][Full Text] [Related]
10. Elevated factor VIII is a risk factor for idiopathic venous thromboembolism in Canada - is it necessary to define a new upper reference range for factor VIII? Wells PS; Langlois NJ; Webster MA; Jaffey J; Anderson JA Thromb Haemost; 2005 May; 93(5):842-6. PubMed ID: 15886797 [TBL] [Abstract][Full Text] [Related]
11. The effect of beta-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolism. Schönauer V; Giannini S; Christ G; Quehenberger P; Bieglmayer C; Stain M; Kyrle PA; Weltermann A Thromb Haemost; 2003 May; 89(5):837-41. PubMed ID: 12719781 [TBL] [Abstract][Full Text] [Related]
12. High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden. Lensen R; Bertina RM; Vandenbroucke JP; Rosendaal FR Br J Haematol; 2001 Aug; 114(2):380-6. PubMed ID: 11529860 [TBL] [Abstract][Full Text] [Related]
13. The risk of venous and arterial thrombosis in hyperhomocysteinemic subjects may be a result of elevated factor VIII levels. Lijfering WM; Veeger NJ; Brouwer JL; van der Meer J Haematologica; 2007 Dec; 92(12):1703-6. PubMed ID: 18055997 [TBL] [Abstract][Full Text] [Related]
14. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Lijfering WM; Brouwer JL; Veeger NJ; Bank I; Coppens M; Middeldorp S; Hamulyák K; Prins MH; Büller HR; van der Meer J Blood; 2009 May; 113(21):5314-22. PubMed ID: 19139080 [TBL] [Abstract][Full Text] [Related]
15. Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism. O'Donnell J; Mumford AD; Manning RA; Laffan MA Br J Haematol; 2001 Dec; 115(3):687-91. PubMed ID: 11736955 [TBL] [Abstract][Full Text] [Related]
16. Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications. Middeldorp S; van de Poel MH; Bank I; Hamulyák K; Libourel EJ; Koopman MM; Prins MH; van der Meer J; Büller HR Thromb Haemost; 2004 Oct; 92(4):787-90. PubMed ID: 15467909 [TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein receptor-related protein polymorphisms in patients with elevated factor VIII coagulant activity and venous thrombosis. Cunningham N; Laffan MA; Manning RA; O'Donnell JS Blood Coagul Fibrinolysis; 2005 Oct; 16(7):465-8. PubMed ID: 16175004 [TBL] [Abstract][Full Text] [Related]
18. The risk of recurrent venous thromboembolism among patients with high factor IX levels. Weltermann A; Eichinger S; Bialonczyk C; Minar E; Hirschl M; Quehenberger P; Schönauer V; Kyrle PA J Thromb Haemost; 2003 Jan; 1(1):28-32. PubMed ID: 12871536 [TBL] [Abstract][Full Text] [Related]
19. Correlation between serum factor VIII:C levels and deep vein thrombosis following gynecological surgery. Liu J; Sang C; Zhang Z; Jiang Y; Wang S; Li Y; Shi X Bioengineered; 2021 Dec; 12(2):9668-9677. PubMed ID: 34845975 [TBL] [Abstract][Full Text] [Related]
20. Difference in absolute risk of venous and arterial thrombosis between familial protein S deficiency type I and type III. Results from a family cohort study to assess the clinical impact of a laboratory test-based classification. Brouwer JL; Veeger NJ; van der Schaaf W; Kluin-Nelemans HC; van der Meer J Br J Haematol; 2005 Mar; 128(5):703-10. PubMed ID: 15725093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]